SCHEMBL7982292

SCHEMBL7982292

CC(C)(C)OC(=O)N1CCC(Nc2nc3ccccc3n2CCOC(F)(F)F)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 2/20 0.47
OPRM1 P35372 2/20 0.44
OPRD1 P41143 2/20 0.44
OGFRL1 Q5TC84 1/20 0.44
MAPT P10636 3/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
BRD4 O60885 1/20 0.43
IDH1 O75874 1/20 0.42
IDH2 P48735 1/20 0.42
KCNH2 Q12809 6/20 0.42
SSTR5 P35346 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988149 0.88 ALDH1A1 (0.48) ALDH1A1LMNAGAAOPRM1OPRD1
SCHEMBL6993631 0.85 KCNH2 (0.47) ALDH1A1LMNAGAAOPRM1OPRD1
SCHEMBL5007368 0.84 ALDH1A1 (0.53) ALDH1A1LMNAGAAOPRM1OPRD1
SCHEMBL3876509 0.82 SMN1; SMN2 (0.50) ALDH1A1LMNAGAAMAPTMAPK1
SCHEMBL7988314 0.82 ALDH1A1 (0.48) ALDH1A1LMNAGAAMAPTMAPK1
SCHEMBL7984810 0.81 ALDH1A1 (0.51) ALDH1A1LMNAGAAMAPTMAPK1
SCHEMBL6997081 0.81 ALDH1A1 (0.52) ALDH1A1LMNAGAAOPRM1OPRD1
SCHEMBL5125428 0.80 ALDH1A1 (0.49) ALDH1A1LMNAGAAOPRM1OPRD1
SCHEMBL3870704 0.80 ALDH1A1 (0.48) ALDH1A1LMNAGAAOPRM1OPRD1
SCHEMBL7623102 0.79 ALDH1A1 (0.52) ALDH1A1OPRM1OPRD1OGFRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211199-B1 HISTAMINE AND TACHYKININ RECEPTOR ANTAGONISTS; ANTIASTHMATICS, ANTIEMETICS; RESPIRATORY SYSTEM DISORDERS, INFLAMMATORY BOWEL DISEASE, CONJUNCTIVITIS AVENTIS PHARMACEUTICALS INC. 2001-04-03 US disclosed